- Home
- ARMN vs OPK Comparison
ARMN vs OPK Comparison
Compare ARMN & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMN
- OPK
- Stock Information
- Founded
- ARMN 1992
- OPK 2007
- Country
- ARMN Canada
- OPK United States
- Employees
- ARMN 3485
- OPK N/A
- Industry
- ARMN
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ARMN
- OPK Health Care
- Exchange
- ARMN Nasdaq
- OPK Nasdaq
- Market Cap
- ARMN 2.0B
- OPK 1.1B
- IPO Year
- ARMN N/A
- OPK 1995
- Fundamental
- Price
- ARMN $9.90
- OPK $1.48
- Analyst Decision
- ARMN Strong Buy
- OPK Buy
- Analyst Count
- ARMN 1
- OPK 3
- Target Price
- ARMN $17.00
- OPK $2.63
- AVG Volume (30 Days)
- ARMN 2.4M
- OPK 2.6M
- Earning Date
- ARMN 11-11-2025
- OPK 11-06-2025
- Dividend Yield
- ARMN N/A
- OPK N/A
- EPS Growth
- ARMN N/A
- OPK N/A
- EPS
- ARMN 0.02
- OPK N/A
- Revenue
- ARMN $646,783,000.00
- OPK $664,029,000.00
- Revenue This Year
- ARMN $49.45
- OPK N/A
- Revenue Next Year
- ARMN $11.08
- OPK $0.84
- P/E Ratio
- ARMN $383.54
- OPK N/A
- Revenue Growth
- ARMN 38.72
- OPK N/A
- 52 Week Low
- ARMN $3.29
- OPK $1.11
- 52 Week High
- ARMN $10.07
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ARMN 65.01
- OPK 59.69
- Support Level
- ARMN $8.89
- OPK $1.41
- Resistance Level
- ARMN $10.07
- OPK $1.49
- Average True Range (ATR)
- ARMN 0.40
- OPK 0.06
- MACD
- ARMN -0.06
- OPK 0.00
- Stochastic Oscillator
- ARMN 84.60
- OPK 75.00
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.